Abstract:Background:Tendinopathy is a common motor system disease that leads to pain and reduced function. Despite its prevalence, our mechanistic understanding is incomplete, leading to limited efficacy of treatment options. Animal models contribute significantly to our understanding of tendinopathy and some therapeutic options. However, the inadequacies of animal models are also evident, largely due to differences in anatomical structure and the complexity of human tendinopathy. Different animal models reproduce different aspects of human tendinopathy and are therefore suitable for different scenarios. This review aims to summarize the existing animal models of tendinopathy and to determine the situations in which each model is appropriate for use, including exploring disease mechanisms and evaluating therapeutic effects.Methods:We reviewed relevant literature in the PubMed database from January 2000 to December 2022 using the specific terms ((tendinopathy) OR (tendinitis)) AND (model) AND ((mice) OR (rat) OR (rabbit) OR (lapin) OR (dog) OR (canine) OR (sheep) OR (goat) OR (horse) OR (equine) OR (pig) OR (swine) OR (primate)). This review summarized different methods for establishing animal models of tendinopathy and classified them according to the pathogenesis they simulate. We then discussed the advantages and disadvantages of each model, and based on this, identified the situations in which each model was suitable for application.Results:For studies that aim to study the pathophysiology of tendinopathy, naturally occurring models, treadmill models, subacromial impingement models and metabolic models are ideal. They are closest to the natural process of tendinopathy in humans. For studies that aim to evaluate the efficacy of possible treatments, the selection should be made according to the pathogenesis simulated by the modeling method. Existing tendinopathy models can be classified into six types according to the pathogenesis they simulate: extracellular matrix synthesis-decomposition imbalance, inflammation, oxidative stress, metabolic disorder, traumatism and mechanical load.Conclusions:The critical factor affecting the translational value of research results is whether the selected model is matched with the research purpose. There is no single optimal model for inducing tendinopathy, and researchers must select the model that is most appropriate for the study they are conducting.The translational potential of this article:The critical factor affecting the translational value of research results is whether the animal model used is compatible with the research purpose. This paper provides a rationale and practical guide for the establishment and selection of animal models of tendinopathy, which is helpful to improve the clinical transformation ability of existing models and develop new models.

An Overview Of Bupivacaine-Induced Morphological Changes: A Novel Animal Model Of Skeletal Muscle Injury

Histomorphological assessment of a rat model of skeletal muscle injury induced by local injection of bupivacaine

Murine Models of Vascular Endothelial Injury: Techniques and Pathophysiology

A Novel Minimally Invasive Surgically Induced Skeletal Muscle Injury Model in Sheep

An ex vivo animal model to study the effect of transverse mechanical loading on skeletal muscle

A mouse model of volumetric muscle loss and therapeutic scaffold implantation

Comparison of in vitro and in vivo Toxicity of Bupivacaine in Musculoskeletal Applications

Modelling skeletal pain harnessing tissue engineering

A novel and efficient murine model for investigating tendon-to-bone healing

Preclinical research studies for treating severe muscular injuries: focus on tissue-engineered strategies

The management, treatment and study of skeletal pain harnessing tissue engineering models

Animal Model for Tendinopathy

[Research progress on in vitro models of cardiomyocyte injury]

Biomimetic scaffolds for regeneration of volumetric muscle loss in skeletal muscle injuries

Biomimetic glycosaminoglycan-based scaffolds improve skeletal muscle regeneration in a Murine volumetric muscle loss model

Cell and Growth Factor-Loaded Keratin Hydrogels for Treatment of Volumetric Muscle Loss in a Mouse Model

Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models

Bone defect animal models for testing efficacy of bone substitute biomaterials

Establishment and pathophysiological evaluation of a novel model of acute compartment syndrome in rats

Suture-anchored cutaneous tension induces persistent hypertrophic scarring in a novel murine model

Induction of Skeletal Muscle Injury by Intramuscular Injection of Cardiotoxin in Mouse.